March 20, 2020 – Winnipeg, Manitoba
Today Research Manitoba announced that they are partnering with the Canadian Institutes of Health Research (CIHR) to invest $800,000 to support three research projects through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity. The researchers are:
- Adolf Ng – An Investigation on Epidemic Logistical Response and Planning: The Case of Novel Coronavirus (Covid-19) – $258,900 – fully funded by Research Manitoba
- Bradley Pickering, Development of field-deployable and point-of-need diagnostics for SARS-CoV-2 using CRISPR-based technology – $411,820 ($270,550 Research Manitoba and $140,270 CIHR)
- Xiao-Jian Yao, Development of a novel DC-targeting vaccine that targets COVID-19 spike protein to control COVID-19 infection – $597,128 ($270,550 Research Manitoba and $326,578 CIHR)
These are 3 of 16 projects supported by CIHR in Manitoba and of 96 projects across Canada that will focus on developing and implementing measures to rapidly detect, manage, and reduce the transmission of COVID-19.
“Investing in COVID-19 research is a global priority,” said Christina Weise, CEO of Research Manitoba. “We are pleased to support these three local teams, which are part of a worldwide scientific effort in response to the COVID-19 pandemic.”
Click here to read the full release
